Join to View Full Profile
Home OfficeMount Laurel, NJ 08054
Phone+1 503-544-7601
Dr. McGann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Judeth McGann is a Pediatric Hematologist and Oncologist based in NJ /remote. She completed her medical degree at Albany Medical College in 1993, followed by a Pediatrics residency and Pediatric Hematology/Oncology fellowship at the University of Rochester. She has contributed significantly to her field with two publications in prominent journals, "The Hypoxic Cytotoxin SR 4233 Increases The Effectiveness of Radioimmunotherapy in Mice With Human Non-Hodgkin's Lymphoma Xenografts" and "The Biodistribution of 111In-Anti-BFGF In A Variety of Tumors. Correlation with Cell-Binding Assays", which have been cited 14 and 1 times, respectively.
Education & Training
University of Rochester Medical CenterFellowship, Pediatric Hematology/Oncology, 1997 - 1999- University of Rochester Medical CenterResidency, Pediatrics, 1993 - 1997
Albany Medical CollegeClass of 1993
Certifications & Licensure
OR State Medical License 2006 - Present
CA State Medical License 2009 - 2027
ME State Medical License Active through 2007
NY State Medical License 1997 - 2001
Publications & Presentations
PubMed
- 74 citationsBortezomib in the rapid reduction of high sustained antibody titers in disorders treated with therapeutic protein: lessons learned from Pompe diseaseSuhrad G. Banugaria, Sean N. Prater, Judeth K. McGann, Jonathan D. Feldman, Jesse A. Tannenbaum
Genetics in Medicine. 2013-02-01 - 378 citationsEmbryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4.Kathleen E. McGrath, Anne D. Koniski, Kathleen M. Maltby, Judeth K. McGann, James Palis
Developmental Biology. 1999-09-15 - 14 citationsTHE HYPOXIC CYTOTOXIN SR 4233 INCREASES THE EFFECTIVENESS OF RADIOIMMUNOTHERAPY IN MICE WITH HUMAN NON-HODGKIN'S LYMPHOMA XENOGRAFTSRichard B. Wilder, Judeth K. McGann, W. Sutherland, Edmund K. Waller, Andrew I. Minchinton
International Journal of Radiation Oncology, Biology, Physics. 1994-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
